Ensuring Healthcare Resilience in Uncertain Times

Om arrangementet

In an era of geopolitical instability, economic shifts, and increasing healthcare demands, how can Norway ensure a resilient and sustainable healthcare system? This meeting will explore the role of international collaboration, public-private partnerships, and strategic investments in securing patients’ access to life-saving medicines, medical technologies, and healthcare services in uncertain times.

The program begins with a panel discussion on "Building Resilience Through Collaboration", featuring leaders from the public and private sectors as well as patient organizations. After a short mingling break, the spotlight turns to a Political Hot Seat on Accountability and Action, where cross-party politicians will face direct questions from panelists and key healthcare stakeholders on how they plan to deliver concrete solutions.

Thank you to our partners Abbvie, Amgen, AstraZeneca, Bayer, BMS, Boehringer-Ingelheim, Boston Scientific, GSK, Johnson & Johnson, Merck, MSD, Medtronic, Novartis, Pfizer, Roche, Sanofi, and Takeda.

Medvirkende

• Ragnhild - Dalen, AmCham Norway Ordstyrer
• Kirsti Nyhus - Market Access Director Scandinavia and Country Lead Norway, Abbvie
• Anne-Lie Öberg - Head of Government Affairs Nordics, Medtronic
• Magne Wang Fredriksen - CEO, LHL
• Truls Vasvik - Member of Parliament, Arbeiderpartiet

Praktisk informasjon

Mer fra programmet